| Absorption |
| Blood-Brain Barrier | BBB+ | 0.7975 |
| Human Intestinal Absorption | HIA+ | 0.9399 |
| Caco-2 Permeability | Caco2+ | 0.8944 |
| P-glycoprotein Substrate | Substrate | 0.5395 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.5866 |
| Non-inhibitor | 0.5087 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8728 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6806 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7357 |
| CYP450 2D6 Substrate | Non-substrate | 0.8835 |
| CYP450 3A4 Substrate | Non-substrate | 0.6252 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.9106 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9230 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7862 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.7933 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6876 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9672 |
| Non-inhibitor | 0.9431 |
| AMES Toxicity | Non AMES toxic | 0.5514 |
| Carcinogens | Non-carcinogens | 0.9518 |
| Fish Toxicity | High FHMT | 0.8392 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9693 |
| Honey Bee Toxicity | High HBT | 0.7557 |
| Biodegradation | Not ready biodegradable | 0.5425 |
| Acute Oral Toxicity | III | 0.8059 |
| Carcinogenicity (Three-class) | Non-required | 0.5260 |